Metastatic Biliary Tract Cancer - Pipeline Review, H2 2015
Global Markets Direct’s, ‘Metastatic Biliary Tract Cancer - Pipeline Review, H2 2015’, provides an overview of the Metastatic Biliary Tract Cancer’s therapeutic pipeline.
This report provides comprehensive information on the therapeutic development for Metastatic Biliary Tract Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Metastatic Biliary Tract Cancer and special features on late-stage and discontinued projects.
Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
- The report provides a snapshot of the global therapeutic landscape of Metastatic Biliary Tract Cancer - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Metastatic Biliary Tract Cancer and enlists all their major and minor projects - The report summarizes all the dormant and discontinued pipeline projects - A review of the Metastatic Biliary Tract Cancer products under development by companies and universities/research institutes based on information derived from company and industry-specific sources - Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages - A detailed assessment of monotherapy and combination therapy pipeline projects - Coverage of the Metastatic Biliary Tract Cancer pipeline on the basis of target, MoA, route of administration and molecule type - Latest news and deals relating related to pipeline products
Reasons to buy
- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Metastatic Biliary Tract Cancer - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Metastatic Biliary Tract Cancer pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Our reports have been used by over 10K customers, including:
Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H2 2018 Summary Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2)...
Serine/Threonine Protein Kinase PLK1 (Polo Like Kinase 1 or Serine/Threonine Protein Kinase 13 or PLK1 or EC 22.214.171.124) - Pipeline Review, H2 2018 Summary According to the recently published report ’SerineThreonine Protein Kinase PLK1 - Pipeline Review, H2 2018’; Serine/Threonine Protein Kinase PLK1...
115 pages •
By Infiniti Research Limited
• Oct 2018
About Animal Vaccines Animal vaccines are biological preparations used to stimulate the immune system of animals to develop adaptive immunity to a pathogen. All animal vaccines undergo regulatory approval processes, the same as human vaccines, before they gain a product license for sale. Technavio’s analysts forecast...
The Global Cancer Monoclonal Antibody Partnering 2012-2018: Deal trends, players, financials and forecasts report provides an understanding and access to the cancer monoclonal antibody partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in cancer monoclonal antibody partnering...
214 pages •
By Persistence Market Research
• Oct 2018
A recent market study titled “Post Herpetic Neuralgia Treatment Market: Global Industry Analysis 2013-2017 & Forecast 2018-2026” consists a comprehensive assessment of the most important market dynamics.On conducting a thorough research on the historic as well as current growth parameters of the Post herpetic neuralgia treatment market, growth...
Type 2 Angiotensin II Receptor (Angiotensin II Type 2 Receptor or AGTR2) - Pipeline Review, H2 2018 Summary Type 2 Angiotensin II Receptor (Angiotensin II Type 2 Receptor or AGTR2) pipeline Target constitutes close to 8 molecules. Out of which approximately 6 molecules are developed by companies...
96 pages •
By Infiniti Research Limited
• Oct 2018
About Polio Polio is a highly contagious disease caused by a human enterovirus of the Picornaviridae family, resulting in paralysis or death. Two types of polio vaccination are available, OPV and IPV. The incidence of polio has been decreasing owing to initiatives by governments globally to drive immunization against...
Vestibular Diseases Global Clinical Trials Review, H2, 2018 Summary GlobalData’s clinical trial report, “Vestibular Diseases Global Clinical Trials Review, H2, 2018" provides an overview of Vestibular Diseases clinical trials scenario.This report provides top line data relating to the clinical trials...
Urea Cycle Disorders Global Clinical Trials Review, H2, 2018 Summary GlobalData’s clinical trial report, “Urea Cycle Disorders Global Clinical Trials Review, H2, 2018" provides an overview of Urea Cycle Disorders clinical trials scenario.This report provides top line data relating to the clinical...